76%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
76%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
76%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
76%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Stryker Corp
Closed
SectorHealthcare
389.19 -1.27
Overview
Share price change
24h
Min
388.37
Max
390.03
Income | 108M 654M |
|---|---|
Sales | -570M 5.9B |
P/E Sector Avg | 52.899 39.564 |
EPS | 2.84 |
Dividend yield | 0.85 |
Profit margin | 11.149 |
Employees | 53,000 |
EBITDA | -985M 837M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +11.35% upside |
Dividend yield Sector Avg | 0.85% 2.40% |
|---|---|
Next Earnings | 31 Jul 2025 |
Next Dividend date | 31 Jul 2025 |
Next Ex Dividend date | 29 Sept 2025 |
Market Cap | 3.3B 151B |
|---|---|
Previous open | 390.46 |
Previous close | 389.19 |
Technical Score
By Trading Central
Confidence
Weak Bullish Evidence
Stryker Corp Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Stryker Corp Forecast
Price Target
By TipRanks
11.35% upside
12 Months Forecast
Average 433.65 USD 11.35%
High 465 USD
Low 400 USD
Based on 17 Wall Street analysts offering 12 month price targets forStryker Corp - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Stryker Corp
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
